Advertisement

Topics

Gilead CEO Defends High Price Of HIV Prevention Drug As Necessary For Research, But Lawmakers Aren’t Buying It

08:44 EDT 17 May 2019 | Kaiser Health News

“This treatment was developed as a result of investment made by the American taxpayers,” said House Oversight Committee Chairman Elijah E. Cummings (D-Md.). “The problem is that Gilead, the company that now sells the drug, charges astronomical prices.” Gilead charged $800 a month for the drug when it was introduced in 2004. The drug now costs nearly $2,000 a month.

Original Article: Gilead CEO Defends High Price Of HIV Prevention Drug As Necessary For Research, But Lawmakers Aren’t Buying It

NEXT ARTICLE

More From BioPortfolio on "Gilead CEO Defends High Price Of HIV Prevention Drug As Necessary For Research, But Lawmakers Aren’t Buying It"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...